Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
Crossref DOI link: https://doi.org/10.1007/s13277-015-3893-1
Published Online: 2015-08-14
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xiaoqing
Fan, Junwei
Li, Yuping
Lin, Shengtao
Shu, Ping
Ni, Jian
Qin, Shengying
Zhang, Zhemin
Text and Data Mining valid from 2015-08-14